PR PolyResearch

Join Free

NASDAQ

BioVie Inc. (BIVI)

♥ 602 Thanks from members

BioVie Inc. (BIVI) displays extreme market volatility driven by positive Phase 2 SUNRISE-PD trial results for bezisterim in early Parkinson's disease, contrasted by sharp selloffs, heavy volume surges, and ongoing shareholder dilution concerns.

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Other Nasdaq Tickers

GraniteShares 2x Long AAPL Daily ETF (AAPB)

Apple Inc. (AAPL)

Direxion Daily AAPL Bear 1X ETF (AAPD)

Ascentage Pharma Group International - American Depository Shares (AAPG)

Direxion Daily AAPL Bull 2X ETF (AAPU)

Rocket Pharmaceuticals, Inc. - Warrant (RCKTW)